Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis (DIAMONDS)
The overall aim of DIAMONDS is to design new diagnostic tests that can tell quickly and accurately what illness a patient has when they come to hospital with common symptoms such as fever. This would help the right treatment to be given to the right patient, at the right time. The diagnostic device is called ‘personalised medicine signature device’ (PMSD). DIAMONDS Search will take place in hospitals within the European Union, UK, Switzerland as well as The Gambia and Asia.
| Imperial PI | Professor Michael Levin |
| Trial Sponsor | Imperial College London |
| Study type | Observational |
| Study status | In recruitment |
Find out more about this study here.